CSIMarket
 
Bio rad Laboratories Inc   (NYSE: BIO)
 
Price: $382.0300 $-4.08 -1.057%
Day's High: $386.3450012207031 Week Perf: 0.28 %
Day's Low: $ 380.36 30 Day Perf: 8.39 %
Volume (M): 30,410 52 Wk High: $ 396.23
Volume (M$): $ 0 52 Wk Avg: $302.40
Open: $390.73 52 Wk Low: $236.73



 Market Capitalization (Millions $) 10,244
 Shares Outstanding (Millions) 27
 Employees 7,450
 Revenues (TTM) (Millions $) 2,589
 Net Income (TTM) (Millions $) 222
 Cash Flow (TTM) (Millions $) 137
 Capital Exp. (TTM) (Millions $) 140

Business Description


Bio-Rad Laboratories Inc. is a prominent multinational corporation specializing in the development and manufacturing of a wide range of products for life science research and clinical diagnostics. The company is based in Hercules, California, and operates in more than 100 countries around the globe, demonstrating its significant international presence and influence within the industry.

History and Background

Founded in 1952 by David and Alice Schwartz, Bio-Rad started as a manufacturer of specialty chemicals intended for the scientific research community. Over the years, the company expanded its focus and expertise, evolving to develop cutting-edge products for various applications in microbiology, genetics, and protein research. This growth was driven by the increasing demand for innovative laboratory solutions, and Bio-Rad quickly earned a reputation as a leader in the field.

Product Portfolio

1. Life Science Division:
- Reagents: Bio-Rad provides a wide array of reagents used in genomic research, including kits for DNA and RNA analysis.
- Instruments: The company manufactures advanced instruments for various life science applications, such as electrophoresis systems, real-time PCR machines, and other analytical devices.
- Software: Bio-Rad develops software solutions that assist researchers in data analysis and management, enhancing workflow efficiency.

2. Clinical Diagnostics Division:
- Bio-Rad’s clinical diagnostics division is known for delivering a diverse range of products aimed at diagnosing and managing diseases. This includes:
- Blood typing and transfusion testing products, which are essential for ensuring safe blood transfusions.
- Systems for monitoring infectious diseases, contributing to public health initiatives.
- Diagnostic tools related to diabetes and autoimmunity, which are increasingly important in preventive healthcare.

Commitment to Sustainability

Bio-Rad is dedicated to sustainability and corporate responsibility. The company has implemented various strategies to reduce waste and enhance laboratory efficiency, thereby minimizing its environmental impact. Their commitment extends to designing products that enable researchers to conduct their work more sustainably, fostering a practice of environmental consciousness within the scientific community.

Philanthropy and Community Engagement

In addition to its commitment to sustainability, Bio-Rad is actively involved in philanthropic efforts, focusing on supporting science education and advancing research initiatives. The company engages in multiple programs aimed at driving interest in science and technology among students and providing grants to support educational institutions and scientific research.

Industry Impact and Recognition

As a leading manufacturer in the life sciences and diagnostics sectors, Bio-Rad Laboratories Inc. has positioned itself as a trusted entity for academic and clinical institutions worldwide. The company is recognized for its innovative solutions, consistently pushing the boundaries of what is possible in research and diagnostics.

Overall, Bio-Rad Laboratories Inc. stands out for its extensive product offerings, commitment to quality and innovation, and proactive approach to corporate responsibility and community engagement. It continues to play a vital role in advancing scientific understanding and improving healthcare outcomes globally.


   Company Address: 1000 Alfred Nobel Drive, Hercules, 94547 CA
   Company Phone Number: 724-7000   Stock Exchange / Ticker: NYSE BIO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
A   -4.67%    
ILMN   -0.43%    
MTD   -5%    
PACB   -3.31%    
RVTY   -0.69%    
TXG        0.54% 
• View Complete Report
   



Business Update

Bio-Rad Laboratories Outshining Rivals with Remarkable Growth and Profitability,

Published Thu, Nov 21 2024 4:47 PM UTC

Bio-Rad Laboratories: Outperforming Rivals in a Competitive Healthcare Landscape As Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) prepares to engage directly with analysts and investors at Citi s 2024 Global Healthcare Conference, the company stands on firm ground. Under the leadership of CEO Norman Schwartz and CFO Roop K. Lakkaraju, Bio-Rad has managed to navigate a tur...

Management Changes

Bio-Rad Laboratories Appoints Roop K. Lakkaraju as CFO to Drive Financial Transformation and Growth

Published Wed, Mar 20 2024 12:30 PM UTC

Bio-Rad Laboratories Appoints Roop K. Lakkaraju as Executive Vice President and Chief Financial Officer
Hercules, California - Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a renowned global leader in life science research and clinical diagnostics products, is pleased to announce the appointment of Roop K. Lakkaraju as its new Executive Vice President and Chief Finan...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 47.81
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 3.96
Price to Sales (Expected) -
Price to Book 1.43
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.92
Working Capital Ratio 2.36
Leverage Ratio (MRQ) 0.43
Total Debt to Equity 0.28
Interest Coverage (TTM) 13.11
Debt Coverage (TTM) 0.34

Per Share Current
Earnings (TTM) 7.99 $
Revenues (TTM) 96.55 $
Cash Flow (TTM) 5.12 $
Cash 33.08 $
Book Value 267.54 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 347,517
Net Income per Employee (TTM) 29,852
Receivable Turnover Ratio (TTM) 5.77
Inventory Turnover Ratio (TTM) 1.62
Asset Turnover Ratio (TTM) 0.26

Profitability Ratios Current
Gross Margin (MRQ) 53.12 %
Operating Margin (MRQ) 11.15 %
Net Margin (MRQ) 57.05 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 36.53 %

Management Effectiveness Current
Return On Assets (TTM) 2.22 %
Return On Investment (TTM) 2.38 %
Return On Equity (TTM) 3.15 %
Dividend Yield -
Pay out Ratio (TTM) -



Bio Rad Laboratories Inc's Segments
UNITED STATES    74.55 % of total Revenue
Europe    66.97 % of total Revenue
Asia Pacific    35.67 % of total Revenue
Americas    13.76 % of total Revenue
Life Science    73.81 % of total Revenue
Clinical Diagnostics    117.14 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.